19 results on '"Dahlof, Bjorn"'
Search Results
2. RELATIONSHIP OF INCIDENT ATRIAL FIBRILLATION TO RENAL FUNCTION IN HYPERTENSIVE PATIENTS WITH ELECTROCARDIOGRAPHIC LEFT VENTRICULAR HYPERTROPHY: THE LIFE STUDY
3. LOWER ACHIEVED SYSTOLIC PRESSURE (≤130 MM HG) IS ASSOCIATED WITH WORSE RENAL FUNCTION BUT A SLOWER DECLINE IN GFR IN HYPERTENSIVE PATIENTS WITH ELECTROCARDIOGRAPHIC LEFT VENTRICULAR HYPERTROPHY: THE LIFE STUDY
4. DOES NEW-ONSET AF LEAD TO CONGESTIVE HEART FAILURE AND VICE VERSA IN HYPERTENSIVE PATIENTS?
5. STATIN USE AND RISK OF NEW DIABETES MELLITUS IN HYPERTENSivE PATIENTS: THE LIFE STUDY
6. RELATIONSHIPS BETWEEN SYSTOLIC BLOOD PRESSURE AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH HIGH RISK HYPERTENSION: AN ANALYSIS OF THE ACCOMPLISH TRIAL
7. LOW IN-TREATMENT HDL CHOLESTEROL LEVELS STRONGLY PREDICT THE DEVELOPMENT OF NEW STROKE: THE LIFE STUDY
8. LOW IN-TREATMENT HDL CHOLESTEROL LEVELS STRONGLY PREDICT SUDDEN CARDIAC DEATH IN HYPERTENSIVE PATIENTS: THE LIFE STUDY
9. ASSOCIATION OF HIGH SERUM GLUCOSE LEVELS WITH LOW HDL CHOLESTEROL LEVELS IN NON-DIABETIC HYPERTENSIVE PATIENTS: IMPLICATIONS FOR THE DEVELOPMENT OF NEW DIABETES
10. INFLUENCE OF DIABETES ON LEFT VENTRICULAR MASS REGRESSION WITH ALISKIREN, LOSARTAN OR BOTH
11. Association of left ventricular hypertrophy regression and heart rate reduction with determinants of myocardial oxygen consumption and cardiovascular events: The LIFE study
12. Hypertensive patients with diabetes have less regression of electrocardiographic left ventricular hypertrophy in response to antihypertensive therapy: The LIFE study
13. Prognostic significance of left ventricular hypertrophy during treatment of hypertension: The LIFE study
14. Gender differences in regression of electrocardiographic left ventricular hypertrophy in response to antihypertensive therapy: The LIFE study
15. Regression of echocardiographic left ventricular hypertrophy in relation to resolution versus persistence of electrocardiographic strain after one year of antihypertensive therapy: the LIFE study
16. 882-1 Anglo-scandinavian cardiac outcomes trial — lipid-lowering arm (ASCOT-LLA): Results in the subgroup of patients with diabetes
17. 1085-170 Benefits of losartan on preventing stroke in patients with isolated systolic hypertension: A LIFE substudy
18. 812-4 Serum uric acid and ischemic stroke risk among hypertensive patients with left ventricular hypertrophy: The losartan intervention for endpoint reduction in hypertension (LIFE) study
19. 1009-166 Pulse pressure as cardiovascular risk marker during losartan or atenolol based therapy in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE trial)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.